The Äyräpää Prize is the most important national medical prize in Finland, which has been awarded annually by the Medical Society Duodecim since 1969. The prize was announced and an award lecture given at the opening ceremony of Lääkäripäivät the at the Helsinki Fair Center on January 9, 2019.
Olli Kallioniemi is awarded for his pioneering contributions to molecular precision medicine, to new technologies and for his work on biological research infrastructures. His current research focuses on development of individualized treatments for cancer patients based on molecular data and drug testing.
Olli Kallioniemi was the founding Director of FIMM from 2007 to 2015 and oversaw the rapid growth of the Institute to a nationally and internationally leading and well-known organization it is today. Currently he is the Director of the Science for Life Laboratory in Stockholm and a Professor at the Karolinska Institute. In addition, he is a part-time Research Director and Group Leader at FIMM.
More information in Finnish:
The Matti Äyräpää Prize is a Finnish prize in medicine awarded by The Finnish Medical Society Duodecim since 1969. It is named after the dentist Matti Äyräpää, who was Duodecim's first chairman.